Michael Lübbert
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 346
- Acute Myeloid Leukemia Research 327
- Chronic Myeloid Leukemia Treatments 46
- Genetics 83
- Myeloproliferative Neoplasms: Diagnosis and Treatment 45
- Co-authors
- Barbara Deschler-Baier (12 shared papers)Rainer Claus (31 shared papers)Manfred Jung (10 shared papers)Pierre W. Wijermans (23 shared papers)Björn W. Hackanson (23 shared papers)Björn Hans Rüter (23 shared papers)P. Wijermans (10 shared papers)Arnold Ganser (40 shared papers)
- Journals
- Blood (104 papers)Leukemia (40 papers)Annals of Hematology (34 papers)Leukemia Research (26 papers)Journal of Clinical Oncology (18 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Michael Lübbert
417 papers receiving 22.5k citations
Michael Lübbert's Hit Papers
Peers
Comparison fields: 5 of 152
- Hematology 14.8k
- Genetics 4.2k
- Molecular Biology 11.0k
- Cancer Research 1.7k
- Oncology 2.8k
Countries citing papers authored by Michael Lübbert
This map shows the geographic impact of Michael Lübbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lübbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lübbert more than expected).
Fields of papers citing papers by Michael Lübbert
This network shows the impact of papers produced by Michael Lübbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lübbert. The network helps show where Michael Lübbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lübbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 426 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Hit paper breakdown → | 2013 | 1262 |
| 2 | New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Hit paper breakdown → | 2007 | 633 |
| 3 | TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome Hit paper breakdown → | 2011 | 564 |
| 4 | New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge Hit paper breakdown → | 2012 | 554 |
| 5 | 2006 | 522 | |
| 6 | 2000 | 488 | |
| 7 | Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group Hit paper breakdown → | 2011 | 474 |
| 8 | Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey Hit paper breakdown → | 2015 | 453 |
| 9 | 2002 | 431 | |
| 10 | 2011 | 410 | |
| 11 | 2011 | 352 | |
| 12 | Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation Hit paper breakdown → | 2014 | 346 |
| 13 | 2010 | 343 | |
| 14 | 2011 | 331 | |
| 15 | 2016 | 327 | |
| 16 | 2016 | 308 | |
| 17 | 2006 | 280 | |
| 18 | 2009 | 267 | |
| 19 | 2018 | 242 | |
| 20 | 2018 | 237 |
About Michael Lübbert
Michael Lübbert is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Oncology, having authored 426 papers that have together received 23.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (327 papers), Epigenetics and DNA Methylation (79 papers), Histone Deacetylase Inhibitors Research (64 papers), Acute Lymphoblastic Leukemia research (63 papers), Chronic Myeloid Leukemia Treatments (46 papers), Retinoids in leukemia and cellular processes (45 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (45 papers) and Protein Degradation and Inhibitors (40 papers). The work is most often cited by research in Hematology (14.8k citations), Genetics (4.2k citations), Molecular Biology (11.0k citations), Cancer Research (1.7k citations) and Oncology (2.8k citations). Michael Lübbert has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Barbara Deschler-Baier, Rainer Claus, Manfred Jung, Pierre W. Wijermans, Björn W. Hackanson, Björn Hans Rüter, P. Wijermans, Arnold Ganser, André Bosly and Aristoteles A. N. Giagounidis. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Leukemia Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.